Mary Anne Papalia

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. ncbi Clinical evaluation of women presenting with low libido and determination of whether androgen therapy might be appropriate
    Mary Anne Papalia
    Women s Health Program, Department of Medicine, Monash University, Alfred Hospital, Commercial Road, Prahran, Victoria 3181, Australia
    Semin Reprod Med 24:86-96. 2006
  2. ncbi Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial
    Susan R Davis
    Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 13:37-45. 2006
  3. ncbi Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial
    Susan Davis
    Women s Health Program, Department of Medicine, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Ann Intern Med 148:569-77. 2008
  4. ncbi Endogenous androgen levels and cardiovascular risk profile in women across the adult life span
    Robin J Bell
    Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Clayton, Victoria, Australia
    Menopause 14:630-8. 2007
  5. ncbi Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study
    Susan R Davis
    Women s Health Program, Department of Medicine, Monash Medical School, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 15:1065-9. 2008
  6. ncbi Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Womens Health (Larchmt) 17:1559-65. 2008
  7. ncbi What is the rationale for androgen therapy for women?
    Mary Anne Papalia
    The Jean Hailes Foundation Research Unit, Clayton, Victoria, Australia
    Treat Endocrinol 2:77-84. 2003
  8. ncbi A clinical update on female androgen insufficiency--testosterone testing and treatment in women presenting with low sexual desire
    Henry G Burger
    The Jean Hailes Foundation, Clayton, Australia
    Sex Health 3:73-8. 2006
  9. ncbi Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial
    Sonal Shah
    NH and MRC Centre of Clinical Research Excellence in the Women's Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 13:600-8. 2006

Detail Information

Publications9

  1. ncbi Clinical evaluation of women presenting with low libido and determination of whether androgen therapy might be appropriate
    Mary Anne Papalia
    Women s Health Program, Department of Medicine, Monash University, Alfred Hospital, Commercial Road, Prahran, Victoria 3181, Australia
    Semin Reprod Med 24:86-96. 2006
    ..This review outlines the various causes of FSD, clinical and biochemical investigations required to diagnose androgen deficiency, and options for treatment of the woman found to have androgen deficiency as a cause of FSD...
  2. ncbi Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial
    Susan R Davis
    Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 13:37-45. 2006
    ..Therefore, the authors investigated the effects of aromatase enzyme inhibition on sexual function, well-being, and mood in estrogen- and T-replete postmenopausal women in a double-blind, randomized, placebo-controlled study...
  3. ncbi Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial
    Susan Davis
    Women s Health Program, Department of Medicine, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Ann Intern Med 148:569-77. 2008
    ..It is not known whether premenopausal women who report low sexual satisfaction and have low circulating testosterone levels will benefit from testosterone therapy...
  4. ncbi Endogenous androgen levels and cardiovascular risk profile in women across the adult life span
    Robin J Bell
    Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Clayton, Victoria, Australia
    Menopause 14:630-8. 2007
    ....
  5. ncbi Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study
    Susan R Davis
    Women s Health Program, Department of Medicine, Monash Medical School, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 15:1065-9. 2008
    ..The aim of the study was to investigate the effects of intranasal E2 with norethisterone (E2/NET) versus oral E2/NET acetate on IGF-I, IGF binding protein 3, and insulin resistance in postmenopausal women...
  6. ncbi Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Womens Health (Larchmt) 17:1559-65. 2008
    ..To report on the issues encountered in the recruitment of healthy naturally menopausal women in the community to a randomized placebo-controlled trial of dehydroepiandrosterone (DHEA) therapy for treatment of loss of sexual desire...
  7. ncbi What is the rationale for androgen therapy for women?
    Mary Anne Papalia
    The Jean Hailes Foundation Research Unit, Clayton, Victoria, Australia
    Treat Endocrinol 2:77-84. 2003
    ..However, clear guidelines regarding the diagnosis of androgen insufficiency, optimal therapeutic doses, and long-term safety remain lacking...
  8. ncbi A clinical update on female androgen insufficiency--testosterone testing and treatment in women presenting with low sexual desire
    Henry G Burger
    The Jean Hailes Foundation, Clayton, Australia
    Sex Health 3:73-8. 2006
    ..Currently, available methods include testosterone implants and testosterone creams, and transdermal patches and sprays are in development...
  9. ncbi Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial
    Sonal Shah
    NH and MRC Centre of Clinical Research Excellence in the Women's Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 13:600-8. 2006
    ..However, our findings highlight that the detection of subtle changes in cognition in well women require the development of sensitive instruments and large randomized, controlled trials...